zotatifin
effector therapeutics
['zotatifin', 'eft226', '$eftr', 'effector therapeutics']
$eftr effector therapeutics reports positive interim results in zotatifin (eft226) phase 1/2 clinical trial at asco 2022 showing safety and tolerability, and initial signals of clinical activity 
GetOnTrade is a news platform to help you stay up-to-date with the latest stock market news. We are not financial advisor(please do your own due diligence).